Centiva Capital’s Thermo Fisher Scientific TMO Stock Holding History

Centiva Capital’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,000	Closed	-$619K	–	2394
2024 Q3	$619K	Hold	1,000	–	–	0.01%	1105
2024 Q2	$553K	Buy	+1,000	New	+$573K	0.01%	1091
2024 Q1	–	Sell	-1,000	Closed	-$531K	–	2255
2023 Q4	$531K	Buy	+1,000	New	+$484K	0.01%	933
2023 Q1	–	Sell	-200	Closed	-$110K	–	1845
2022 Q4	$110K	Hold	200	–	–	﹤0.01%	1176
2022 Q3	$101K	Hold	200	–	–	﹤0.01%	1292
2022 Q2	$109K	Buy	+200	New	+$110K	﹤0.01%	1411
2021 Q4	–	Sell	-100	Closed	-$57K	–	1544
2021 Q3	$57K	Buy	+100	New	+$54.9K	﹤0.01%	1128
2020 Q3	–	Sell	-500	Closed	-$181K	–	876
2020 Q2	$181K	Sell	500 -600	-55%	-$201K	0.01%	538
2020 Q1	$312K	Buy	+1,100	New	+$347K	0.01%	376

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Centiva Capital's TMO Position: Q3 2025 in Review

Centiva Capital sold out of Thermo Fisher Scientific (TMO) in Q3 2025, closing a stake of 14,505 shares — an estimated $5.88M sold.

Centiva Capital first reported a position in TMO in Q4 2019 and held it in 19 quarters. The position peaked at $13.5M in Q2 2024. 2,515 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

Centiva Capital reported no remaining Thermo Fisher Scientific position as of Q3 2025 after selling out during the quarter.
Centiva Capital sold 14,505 Thermo Fisher Scientific shares in Q3 2025, an estimated $5.88M.
Centiva Capital first reported a position in Thermo Fisher Scientific in Q4 2019 and held it in 19 quarters.
Centiva Capital's Thermo Fisher Scientific position peaked at $13.5M in Q2 2024.
2,515 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on Centiva Capital's 13F filing for Q3 2025, filed 14 Nov 2025.